Tilray Brands Inc (NASDAQ:TLRY) is one of the best CBD stocks to buy right now. Although Tilray Brands Inc (NASDAQ:TLRY) stock is up only a modest 19% over the past year, analysts see the stock soaring more than 50% over the next 12 months.

On May 26, Tilray Medical joined talks on medical cannabis regulations in London. Tilray Medical is a subsidiary of Tilray Brands that offers a wide range of medical-grade CBD-products. The London talks brought together healthcare professionals, researchers, industry leaders, and policymakers to explore the future of medical cannabis innovation and regulation in Europe.

The forum included a panel discussion focused on clinical research, patient outcomes, and public health data to help shape evidence-based regulatory approaches.

According to José Tempero, Tilray Medical’s director of international medical affairs, the European medical cannabis field continues to evolve. In light of this, research and clinical evidence are critical to developing responsible frameworks and improving patient access.

Tilray Medical is a leading supplier of medical cannabis across five continents. According to Tilray Brands, the medical subsidiary has deep regulatory expertise and is well-positioned to continue advancing patient care across international markets.

Tilray Brands Inc (NASDAQ:TLRY) is a consumer packaged goods company. Its portfolio includes craft beer, spirits, medical and adult-use cannabis, and hemp wellness products. It operates dozens of brands and has footprints in more than 20 countries across the Americas and Europe.

While we acknowledge the potential of TLRY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Most Buzzing AI Semiconductor Stocks to Buy in 2026 and 11 Best Medical Technology Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.